Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Veradermics Incorporated (MANE) had Tangible Shareholders Equity of $390.64M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-30.01M |
|
-- |
|
-- |
|
$29.86M |
|
$-29.86M |
|
$2.63M |
|
$-27.23M |
|
$-27.23M |
|
$-27.23M |
|
$-27.23M |
|
$-27.23M |
|
$-27.23M |
|
$-29.86M |
|
$-29.86M |
|
22.70M |
|
22.70M |
|
$-1.32 |
|
$-1.32 |
|
| Balance Sheet Financials | |
$397.07M |
|
$0.02M |
|
$0.29M |
|
$397.36M |
|
$6.72M |
|
-- |
|
-- |
|
$6.72M |
|
$390.64M |
|
|
Tangible Shareholders Equity |
$390.64M |
$390.64M |
|
37.34M |
|
| Cash Flow Statement Financials | |
$-21.17M |
|
$-101.30M |
|
$269.11M |
|
$21.77M |
|
$168.41M |
|
$146.65M |
|
$5.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
59.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.97% |
|
-6.97% |
|
-6.85% |
|
-6.97% |
|
$10.46 |
|
$-0.93 |
|
$-0.93 |
|